BPA Call W81K0020A0003-W81K0024F0098

Award Date 6/10/24
Potential Completion Date 9/30/24
Potential Value $38K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $57,600 firm fixed-price purchase order awarded by the Indian Health Service (IHS), a civilian agency within the Department of Health and Human Services (HHS), to Nephron Sterile Compounding Center LLC, a small disadvantaged business. The contract is for a Blanket Purchase Agreement (BPA) to provide pharmaceutical products and supplies, including medications such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for...
This firm fixed price contract for $12,000 was awarded by the Defense Health Agency to Nephron Sterile Compounding Center LLC on October 6, 2022. The contract is associated with a Blanket Purchase Agreement to provide buffered lidocaine buffer in sodium bicarbonate, as well as other pharmaceutical products and supplies, through September 30, 2023. Nephron 503B Outsourcing Facility will deliver the specified medications and general pharmacy supplies. No set-aside designation was used for this...
This firm fixed price purchase order for $7,902 awards Nephron Sterile Compounding Center LLC to provide various pharmacy supplies under a Blanket Purchase Agreement with the Department of Health and Human Services Indian Health Service through February 2024. The BPA facilitates recurring procurement of supplies to support the agency's pharmacy programs. No set-aside designation applies to this award made to the woman-owned small business for products including medications like Phenylephrine HCI...
This is a firm fixed price contract awarded by the Defense Health Agency to The Compounding Center Inc., a minority-owned and self-certified small disadvantaged business. The $300,000.00 contract is for the delivery of specialized pharmaceuticals and compounded medications to address shortages impacting patient care at military and civilian treatment facilities. The Compounding Center has received over $700,000 in prior awards from the Department of Health and Human Services and Defense Health...
This federal contract award, valued at $1,943.55, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of various pharmaceutical products, including but not limited to flumazenil injections, prednisone tablets, ampicillin injections, clotrimazole cream, epinephrine auto-injectors, contraceptive products,...
This federal contract award, valued at $4,354.20, was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain division to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, that runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery...
This contract award is for the delivery of various shortage pharmaceuticals to the Defense Health Agency, an agency within the Department of Defense. The prime contractor, The Compounding Center Inc., is a minority-owned, small disadvantaged business that provides specialized pharmaceutical compounds and medical supplies to government agencies. The contract is a blanket purchase agreement with a ceiling value of $300,000.00, allowing for the expedited acquisition of customized medications and...
This federal contract award was issued by the Defense Health Agency to The Compounding Center Inc., a minority-owned, self-certified small disadvantaged business. The $300,000.00 firm fixed price contract is a Blanket Purchase Agreement (BPA) call to provide shortage pharmaceuticals for the Walter Reed National Military Medical Center (WRNMMC). The contract has a completion date of September 30, 2016 and does not have a set-aside designation. The Compounding Center has received over $700,000...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,377.96 contract is for the provision of 50ml syringes of 8.4% sodium bicarbonate solution, a specialized medical supply used in military healthcare facilities. The contract has an ultimate completion date of January 8, 2025 and is not associated with any set-aside designations. DMS...
This federal contract award, valued at $2,324.43, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999 and runs through November 2026. The award is for the delivery of 0.9% sodium chloride solution in 100 ml containers. This medical supply contract supports military treatment facilities, veterans' healthcare programs,...
  • W81K0020A0003
    Blanket Purchase Agreement
  • W81K0020A0003-W81K0024F0098
    BPA Call

This is a federal contract award from the Defense Health Agency (DHA) to Nephron Sterile Compounding Center LLC, a self-certified small disadvantaged business and woman-owned limited liability company. The contract, valued at $37,586.64, is for the provision of various pharmaceutical products and supplies, including specific medications such as Phenylephrine HCI Injection, Succinylcholine Chloride for Injection, Preservative Free Rocuronium Bromide for Injection, and Buffered Lidocaine Buffer in Sodium Bicarbonate. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed price, and has an ultimate completion date of September 30, 2024. The contract is not set-aside.

Generated 3/27/25, 10:05 AM